journal article·2025-03

HUVECs’ Expressway Based on Magnesium Ion Doped Hierarchical Scaffold for Rapid Angiogenesis and Bone Ingrowth

Peng Yu, Fan‐Yuan Yu, Fei‐Fei Li, Jia‐Yi Wu, Zheng‐Min Zhang, Yun‐Fei Tian, Zhi‐Yong Qian

Advanced Functional Materials· Volume 35· Issue 12
Publisher page

Abstract

Abstract Delayed union or nonunion remains an extremely challenging predicament even after the application of currently available engineering scaffolds for the treatment of critical‐sized bone defects. The angiogenesis throughout the artificial bone repair scaffold to achieve “angiogenic‐osteogenic coupling” is regarded as an effective approach to solving this issue. The newly formed blood vessels can accelerate the supply of oxygen and nutrients, thereby triggering subsequent bone regeneration. Therefore, scaffolds featuring an angiogenic microenvironment that promotes cell adhesion and migration should be designed for superior bone repair. Herein, a magnesium ion‐doped hierarchical scaffold is fabricated using a polymer blend system of chitosan/polyethyleneimine with inherent micro‐phase separation and complexation. Due to the microscopic sea‐island structure and the stable doped magnesium ions, the cell adhesion behavior underwent a significant transformation. Meanwhile, the pathways related to cell adhesion, migration, and angiogenesis are activated, and the critical target thrombospondin 1 is upregulated. Consequently, the cell adhesion capacity is augmented, 6 times the cell migration rate is attained, and the angiogenesis of human umbilical vein endothelial cells is significantly expedited. Eventually, rapid bone ingrowth and satisfactory bone defect repair are approximated in vivo, making the composite scaffold a promising clinical candidate for bone engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotherapy Cancer Center and State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu 610041 China

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan 610041 China

College of Polymer Science and Engineering State Key Laboratory of Polymer Materials Engineering Sichuan University Chengdu Sichuan 610065 China

Analytical & Testing Center Sichuan University Chengdu Sichuan 610065 China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · Natural Science Foundation of Sichuan Province

References (64)

Show source-provided references
1. 10.1097/TA.0b013e31819adc5010.1097/TA.0b013e31819adc50 ↗
2. Feng P. · Adv. Funct. Mater. · 2023 · 33
3. 10.1038/s41578-020-0204-210.1038/s41578-020-0204-2 ↗
4. 10.1016/j.injury.2021.01.04310.1016/j.injury.2021.01.043 ↗
5. 10.1007/s13770-016-0001-610.1007/s13770-016-0001-6 ↗
6. 10.1007/s00223-017-0294-z10.1007/s00223-017-0294-z ↗
7. 10.2147/IJN.S9034310.2147/IJN.S90343 ↗
8. W. C.Liu S.Chen L.Zheng L.Qin A. H.Mater 2017 6 1600434.10.1002/adhm.201600434 ↗
9. 10.1002/adfm.20240074510.1002/adfm.202400745 ↗
10. 10.1007/s11538-013-9826-510.1007/s11538-013-9826-5 ↗
11. 10.1021/acsnano.9b0472310.1021/acsnano.9b04723 ↗
12. 10.3390/ijms1908234310.3390/ijms19082343 ↗
13. 10.1038/s12276-018-0187-x10.1038/s12276-018-0187-x ↗
14. 10.1002/adma.20210792210.1002/adma.202107922 ↗
15. 10.1002/adma.20160640710.1002/adma.201606407 ↗
16. 10.1088/0953-8984/28/18/18300110.1088/0953-8984/28/18/183001 ↗
17. 10.1016/j.biomaterials.2021.12123910.1016/j.biomaterials.2021.121239 ↗
18. Qiao W. · Nat. Commun. · 2021 · 12
19. 10.1016/j.biomaterials.2018.10.01510.1016/j.biomaterials.2018.10.015 ↗
20. 10.1126/sciadv.abj108310.1126/sciadv.abj1083 ↗
21. 10.1002/mco2.36510.1002/mco2.365 ↗
22. 10.1039/C6BM00290K10.1039/C6BM00290K ↗
23. 10.2741/161010.2741/1610 ↗
24. 10.1016/j.biomaterials.2019.01.01310.1016/j.biomaterials.2019.01.013 ↗
25. 10.1016/j.biomaterials.2020.11982810.1016/j.biomaterials.2020.119828 ↗
26. 10.1016/j.carbpol.2020.11604310.1016/j.carbpol.2020.116043 ↗
27. 10.1002/adfm.20240314510.1002/adfm.202403145 ↗
28. 10.1021/acsnano.9b0048910.1021/acsnano.9b00489 ↗
29. 10.1002/adfm.20211027710.1002/adfm.202110277 ↗
30. Haider A. · Chem. Soc. · 2020 · 24 · 186
31. 10.1002/adfm.20220001110.1002/adfm.202200011 ↗
32. 10.1016/j.memsci.2016.12.03110.1016/j.memsci.2016.12.031 ↗
33. 10.1126/science.123815910.1126/science.1238159 ↗
34. 10.1016/j.biomaterials.2003.12.00510.1016/j.biomaterials.2003.12.005 ↗
35. 10.1016/j.supflu.2014.10.02910.1016/j.supflu.2014.10.029 ↗
36. 10.1002/advs.20220188110.1002/advs.202201881 ↗
37. 10.1021/acsami.9b1944010.1021/acsami.9b19440 ↗
38. 10.1021/acssuschemeng.6b0225410.1021/acssuschemeng.6b02254 ↗
39. 10.1021/acsami.5b0424510.1021/acsami.5b04245 ↗
40. 10.1021/la011278n10.1021/la011278n ↗
41. 10.1016/j.saa.2011.02.05110.1016/j.saa.2011.02.051 ↗
42. 10.1016/j.physe.2012.04.02210.1016/j.physe.2012.04.022 ↗
43. 10.1002/pat.582210.1002/pat.5822 ↗
44. 10.1016/j.carbpol.2016.09.00110.1016/j.carbpol.2016.09.001 ↗
45. 10.1021/acs.chemmater.5b0279010.1021/acs.chemmater.5b02790 ↗
46. 10.1063/1.46747010.1063/1.467470 ↗
47. 10.1063/1.47010810.1063/1.470108 ↗
48. 10.1103/PhysRevLett.94.07600110.1103/PhysRevLett.94.076001 ↗
49. 10.1021/ma801232j10.1021/ma801232j ↗
50. 10.1063/1.346692110.1063/1.3466921 ↗
51. 10.1524/zkri.220.5.567.6507510.1524/zkri.220.5.567.65075 ↗
52. 10.1038/s41467-019-08480-y10.1038/s41467-019-08480-y ↗
53. 10.3390/ijms24171331210.3390/ijms241713312 ↗
54. 10.1158/0008-5472.CAN-11-112410.1158/0008-5472.CAN-11-1124 ↗
55. Isenberg J. S. · Cytogenet. Oncol. Haematol. · 2020 · 24 · 291
56. 10.1002/cbin.1212610.1002/cbin.12126 ↗
57. 10.1016/j.joms.2005.05.30310.1016/j.joms.2005.05.303 ↗
58. 10.1016/j.biomaterials.2011.07.03510.1016/j.biomaterials.2011.07.035 ↗
59. 10.1038/s41368-022-00159-310.1038/s41368-022-00159-3 ↗
60. 10.1002/stem.319210.1002/stem.3192 ↗
61. 10.1126/sciadv.abn497710.1126/sciadv.abn4977 ↗
62. Peng Y. · J. L. Crane. · 2020 · 10 · 426
63. Gentile M. T. · J. Vis. Exp. · 2019 · 148
64. 10.1016/j.ebiom.2017.12.01410.1016/j.ebiom.2017.12.014 ↗